Background: The pains of labor result in a maternal stress response, which is neither beneficial for the fetus nor the mother ^[1]. Hence, maternal pain relief not only benefits the parturient, but her neonate also ^[2]. Studies have also shown that the newer, low-dose regimes do not have a statistically significant impact on the duration of labor and breast feeding and also that these reduce the instrumental delivery rates thus improving maternal and foetal safety ^[3]. Central neuraxial analgesia is the most versatile method of labour analgesia and the gold standard technique for pain control in obstetrics that is currently available ^[5]. The availability of newer local anaesthetics like ropivacaine and levo-bupivacaine have contributed towards the increased maternal safety in terms of being less cardiotoxic after an inadvertent IV injection.